Team headed by Jean-Philippe Collet
The main goal of team 2 is to improve knowledge in cardiovascular medicine, from treatment strategies to education for primary prevention mainly in the field of atherothrombosis. Expanding of the group led to new areas of investigation including now cardiovascular epidemiology, education but also new technologies. Our cardiovascular research is broad going from in vitro experimental models to randomized clinical trials.
This team is attached to the doctoral school 394 “Physiologie, Physiopathologie et Thérapeutique”.